CAR-T in solid tumors: Obstacles and potential strategies
Acta Pharmaceutica Sinica B · 2026-11 · 16 (11) · 7184-7202
DOI: 10.1016/j.apsb.2026.07.047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Ziyi Ding und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, University of Chinese Academy of Sciences, …. Die Arbeit nennt 249 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 201203, China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, China.
Förderung
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Ding, Z., Li, Y., & Huang, M. (2026). CAR-T in solid tumors: Obstacles and potential strategies. Acta Pharmaceutica Sinica B, 16(11), 7184-7202. https://doi.org/10.1016/j.apsb.2026.07.047
Vancouver
Ding Z, Li Y, Huang M. CAR-T in solid tumors: Obstacles and potential strategies. Acta Pharmaceutica Sinica B. 2026;16(11):7184-7202. doi:10.1016/j.apsb.2026.07.047
BibTeX
@article{Ding2026,
author = {Ding, Ziyi and Li, Yize and Huang, Min},
title = {CAR-T in solid tumors: Obstacles and potential strategies},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {11},
pages = {7184--7202},
doi = {10.1016/j.apsb.2026.07.047}
}
EUVIMED